Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2024 for a quick interview about the current and future state of pharma marketing.
Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner
Compliance Considerations for Direct-to-Patient Programs: What Pharma Needs in a Trusted Partner By Pouria Sanae, CEO, ixlayer As biopharma companies expand their use of direct-to-patient (DTP) programs, the compliance landscape
